User profiles for Eric E. Smith

Eric E. Smith

University of Calgary
Verified email at ucalgary.ca
Cited by 64738

Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration

JM Wardlaw, EE Smith, GJ Biessels… - The Lancet …, 2013 - thelancet.com
Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features
seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter …

[HTML][HTML] Randomized assessment of rapid endovascular treatment of ischemic stroke

…, PA Barber, SB Coutts, EE Smith… - … England Journal of …, 2015 - Mass Medical Soc
Background Among patients with a proximal vessel occlusion in the anterior circulation, 60
to 80% of patients die within 90 days after stroke onset or do not regain functional …

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

EE Smith, DG Buckley, Z Wu… - Proceedings of the …, 2006 - National Acad Sciences
In many human infections, hosts and pathogens coexist for years or decades. Important
examples include HIV, herpes viruses, tuberculosis, leprosy, and malaria. With the exception of …

Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke

JL Saver, GC Fonarow, EE Smith, MJ Reeves… - Jama, 2013 - jamanetwork.com
Importance Randomized clinical trials suggest the benefit of intravenous tissue-type plasminogen
activator (tPA) in acute ischemic stroke is time dependent. However, modest sample …

Variants conferring risk of atrial fibrillation on chromosome 4q25

…, M Sale, P Kelly, CA MacRae, EE Smith… - Nature, 2007 - nature.com
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans and is
characterized by chaotic electrical activity of the atria 1 . It affects one in ten individuals over the …

Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle …

GC Fonarow, EE Smith, JL Saver, MJ Reeves… - Circulation, 2011 - Am Heart Assoc
Background— The benefits of intravenous tissue-type plasminogen activator (tPA) in acute
ischemic stroke are time dependent, and guidelines recommend an arrival to treatment …

Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association

…, JH Lichtman, LD Lisabeth, LH Schwamm, EE Smith… - Stroke, 2014 - Am Heart Assoc
Background and Purpose— Stroke mortality has been declining since the early 20th century.
The reasons for this are not completely understood, although the decline is welcome. As a …

2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart …

…, KW Mahaffey, R Mehran, SE Nissen, EE Smith… - Circulation, 2015 - Am Heart Assoc
This publication, commissioned by the ACC/AHA, is the product of a novel collaboration
between the ACC and AHA, the US Food and Drug Administration (FDA), and the Standardized …

Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative

GC Fonarow, X Zhao, EE Smith, JL Saver, MJ Reeves… - Jama, 2014 - jamanetwork.com
Importance The benefits of intravenous tissue plasminogen activator (tPA) in patients with
acute ischemic stroke (AIS) are time dependent and guidelines recommend a door-to-needle (…

Get With the Guidelines–Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack

…, MJ Reeves, W Pan, MR Frankel, EE Smith… - Circulation, 2009 - Am Heart Assoc
Background— Adherence to evidence-based guidelines for treatment of stroke or transient
ischemic attack is suboptimal. We sought to establish whether participation in Get With the …